Literature DB >> 26694753

Comprehensive Characterization of Relationship Between Higher-Order Structure and FcRn Binding Affinity of Stress-Exposed Monoclonal Antibodies.

Daisuke Tsuchida1,2, Katsuyoshi Yamazaki3, Satoko Akashi4.   

Abstract

PURPOSE: In biopharmaceutical development, information regarding higher-order structure (HOS) is important to verify quality and characterize protein derivatives. In this study, we aimed to characterize the association between HOS and pharmacokinetic property of a stress-exposed monoclonal antibody (mAb).
METHODS: Purity, primary structure, thermal stability, and HOS were evaluated for mAbs exposed to heat, photo-irradiation, and chemical oxidation. To investigate conformation of stress-exposed mAbs, hydrogen/deuterium exchange coupled with mass spectrometry (HDX-MS) was utilized.
RESULTS: No distinct difference in secondary or tertiary structure between stress-exposed and non-stressed samples was found by conventional spectroscopic techniques. In binding activity with the neonatal Fc receptor (FcRn), however, a marked decline was observed for force-oxidized mAb and a slight decline was observed for heat- and photodegraded mAbs. Using differential scanning calorimetry, a change in thermal stability was observed in the CH2 domain for all the stress-exposed samples. Using HDX-MS analyses, individual regions with altered conformation could be identified for heat-degraded and force-oxidized samples.
CONCLUSIONS: These findings indicate that comprehensive study is important for detecting conformational changes and helpful for predicting biophysical property, and that the evaluation of HOS using several analytical techniques is indispensable for confirming biopharmaceutical quality.

Entities:  

Keywords:  FcRn; HDX–MS; higher-order structure; monoclonal antibody

Mesh:

Substances:

Year:  2015        PMID: 26694753     DOI: 10.1007/s11095-015-1845-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  31 in total

1.  The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein.

Authors:  A W Vermeer; W Norde
Journal:  Biophys J       Date:  2000-01       Impact factor: 4.033

Review 2.  Fc gamma receptors.

Authors:  Joël F G Cohen-Solal; Lydie Cassard; Wolf-Herman Fridman; Catherine Sautès-Fridman
Journal:  Immunol Lett       Date:  2004-04-15       Impact factor: 3.685

Review 3.  Strategies and challenges for the next generation of therapeutic antibodies.

Authors:  Alain Beck; Thierry Wurch; Christian Bailly; Nathalie Corvaia
Journal:  Nat Rev Immunol       Date:  2010-05       Impact factor: 53.106

4.  Non-enzymatic hinge region fragmentation of antibodies in solution.

Authors:  Armando J Cordoba; Bao-Jen Shyong; Deirdre Breen; Reed J Harris
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-04-25       Impact factor: 3.205

Review 5.  Antibody structure, instability, and formulation.

Authors:  Wei Wang; Satish Singh; David L Zeng; Kevin King; Sandeep Nema
Journal:  J Pharm Sci       Date:  2007-01       Impact factor: 3.534

6.  Distinct aggregation mechanisms of monoclonal antibody under thermal and freeze-thaw stresses revealed by hydrogen exchange.

Authors:  Aming Zhang; Satish K Singh; Michael R Shirts; Sandeep Kumar; Erik J Fernandez
Journal:  Pharm Res       Date:  2011-07-30       Impact factor: 4.200

Review 7.  The therapeutic monoclonal antibody market.

Authors:  Dawn M Ecker; Susan Dana Jones; Howard L Levine
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 8.  IgG Fc receptors.

Authors:  J V Ravetch; S Bolland
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

9.  Identification of methionine sulfoxide diastereomers in immunoglobulin gamma antibodies using methionine sulfoxide reductase enzymes.

Authors:  Hui K Khor; Michael E Jacoby; Thomas C Squier; Grace C Chu; Dirk Chelius
Journal:  MAbs       Date:  2010-05-11       Impact factor: 5.857

10.  Determination of the mechanism of action of anti-FasL antibody by epitope mapping and homology modeling.

Authors:  Victor H Obungu; Valentina Gelfanova; Radhakrishnan Rathnachalam; Anna Bailey; Joanne Sloan-Lancaster; Lihua Huang
Journal:  Biochemistry       Date:  2009-08-04       Impact factor: 3.162

View more
  6 in total

1.  High-Throughput Assessment of Structural Continuity in Biologics.

Authors:  Caterina Musetti; Mark F Bean; Geoffrey T Quinque; Christopher Kwiatkowski; Lawrence M Szewczuk; John Baldoni; Matthew A Zajac
Journal:  Anal Chem       Date:  2018-02-08       Impact factor: 6.986

Review 2.  Molecular and functional analysis of monoclonal antibodies in support of biologics development.

Authors:  Xin Wang; Zhiqiang An; Wenxin Luo; Ningshao Xia; Qinjian Zhao
Journal:  Protein Cell       Date:  2017-07-21       Impact factor: 14.870

Review 3.  Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins.

Authors:  Liming Liu
Journal:  Protein Cell       Date:  2017-04-19       Impact factor: 14.870

4.  Advanced assessment of the physicochemical characteristics of Remicade® and Inflectra® by sensitive LC/MS techniques.

Authors:  Jing Fang; Catalin Doneanu; William R Alley; Ying Qing Yu; Alain Beck; Weibin Chen
Journal:  MAbs       Date:  2016-06-03       Impact factor: 5.857

5.  Identification of critical chemical modifications by size exclusion chromatography of stressed antibody-target complexes with competitive binding.

Authors:  Rachel Liuqing Shi; Gang Xiao; Thomas M Dillon; Arnold McAuley; Margaret S Ricci; Pavel V Bondarenko
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

Review 6.  In Translation: FcRn across the Therapeutic Spectrum.

Authors:  Timothy Qi; Yanguang Cao
Journal:  Int J Mol Sci       Date:  2021-03-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.